- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Human Tissue (Quality and Safety for Human Application) Regulations 2007, Section 7A.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
7A.—(1) No person may import tissues or cells intended for human application into [F3Northern Ireland] from an EEA state F4..., unless—
(a)the import is from a tissue establishment which is accredited, designated, authorised or licensed under the laws or other measures adopted in an EEA stateF5... for the purpose of implementing the first, second and third Directives; or
(b)the import—
(i)is from a person who is approved to procure tissues or cells intended for human application under the laws or other measures adopted in an EEA state F6... for the purpose of implementing the first, second or third Directives; and
(ii)follows the procurement of those tissues or cells in conditions accredited, designated, authorised or licensed under the laws or other measures adopted in an EEA stateF7... for the purpose of implementing the first, second or third Directives.]
Textual Amendments
F1Reg. 7A inserted (6.3.2018 for specified purposes, 1.4.2018 in so far as not already in force) by The Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2018 (S.I. 2018/335), regs. 1(2)(3), 3(2)
F2Reg. 7A heading substituted (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(7)(a) (as substituted by S.I. 2020/1306, regs. 1, 10); 2020 c. 1, Sch. 5 para. 1(1)
F3Words in reg. 7A(1) substituted (31.12.2020) by The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(7)(b)(i) (as substituted by S.I. 2020/1306, regs. 1, 10); 2020 c. 1, Sch. 5 para. 1(1)
F4Words in reg. 7A(1) omitted (31.12.2020) by virtue of The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(7)(b)(ii) (as substituted by S.I. 2020/1306, regs. 1, 10); 2020 c. 1, Sch. 5 para. 1(1)
F5Words in reg. 7A(1)(a) omitted (31.12.2020) by virtue of The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(7)(c) (as substituted by S.I. 2020/1306, regs. 1, 10); 2020 c. 1, Sch. 5 para. 1(1)
F6Words in reg. 7A(1)(b)(i) omitted (31.12.2020) by virtue of The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(7)(d) (as substituted by S.I. 2020/1306, regs. 1, 10); 2020 c. 1, Sch. 5 para. 1(1)
F7Words in reg. 7A(1)(b)(ii) omitted (31.12.2020) by virtue of The Human Tissue (Quality and Safety for Human Application) (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/481), regs. 1, 3(7)(e) (as substituted by S.I. 2020/1306, regs. 1, 10); 2020 c. 1, Sch. 5 para. 1(1)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: